tiprankstipranks
TherapeuticsMD (TXMD)
NASDAQ:TXMD
US Market
TXMD
TherapeuticsMD
RESEARCH TOOLSreports

TherapeuticsMD (TXMD) Income Statement

2,247 Followers

TherapeuticsMD Income Statement

Last quarter (Q4 2025), TherapeuticsMD's total revenue was $893.00K, an increase of 33.88% from the same quarter last year. In Q4, TherapeuticsMD's net income was $-619.00K. See TherapeuticsMD’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Dec 21
Total Revenue
$ 3.02M$ 1.76M$ 1.30M$ 69.96M$ 2.57M
Gross Profit
$ 1.83M$ 1.76M$ 1.30M$ 68.57M$ 1.17M
Operating Expenses
$ 6.04M$ 6.52M$ 9.82M$ 67.38M$ 80.75M
Depreciation and Amortization
$ 1.19M$ 509.00K$ 438.50K$ 1.20M$ 736.00K
EBITDA
$ -3.02M$ -2.98M$ -8.08M$ 11.86M$ -70.84M
Operating Income
$ -4.21M$ -4.76M$ -8.52M$ 1.19M$ -79.58M
Other Income/Expenses
$ 3.56M$ 2.42M$ 781.00K$ -117.00K$ 272.00K
Pretax Income
$ -653.00K$ -2.34M$ -7.74M$ 1.07M$ -79.31M
Net Income
$ -569.00K$ -2.18M$ -10.28M$ 112.00M$ -172.41M
Per Share Metrics
Basic EPS
$ -0.05$ -0.19$ -0.55$ -10.35$ -25.83
Diluted EPS
$ -0.05$ -0.19$ -0.74$ -10.35$ -25.83
Weighted Average Shares Outstanding
 11.57M 11.53M 10.44M 9.03M 7.96M
Weighted Average Shares Outstanding (Diluted)
 11.57M 11.53M 10.44M 9.03M 7.96M
Currency in USD

TherapeuticsMD Earnings and Revenue History